macra

CMS Seeks Expertise in Cancer Screening, Genetic Testing, Clinical Epidemiology, Psychopharmacology, Screening/Diagnostic Testing Analysis and Vascular Surgery for MEDCAC Nominations

October 22, 2019

McDermott+Consulting

The Centers for Medicare and Medicaid Services (CMS) is currently seeking nominations for members of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). The notice for nominations can be found here. Nominations and supporting documents are due by Monday, November 18, 2019.

MEDCAC provides clinical expertise to the Secretary of the Department of Health and Human Services (HHS) and the CMS Administrator in the Medicare coverage determination process. CMS refers topics to MEDCAC when there are controversies among experts as to the clinical effectiveness of an item or service or there is insufficient evidence in the current scientific literature to decide on Medicare coverage.

The Committee is made up of 100 advising members, 90 of which are standing members and the remaining 10 represent industry. Members are invited to serve for overlapping 2-year terms. As of June 2020, 25 membership terms are set to expire. Of the 25 memberships expiring, two are industry representatives, five are patient advocates and the remaining 18 membership openings are for the at-large standing MEDCAC membership. While accepting nominations from all sectors, the Committee has indicated it has a particular interest for experts in cancer screening, genetic testing, clinical epidemiology, psychopharmacology, screening and diagnostic testing analysis, and vascular surgery.

More information about the MEDCAC can be found here.

 

_________________________________________________________________

For more information visit the McDermottPlus Payment Innovation Resource Center or contact Sheila Madhani at 202-204-1459 or smadhani@mcdermottplus.com.

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope